» Articles » PMID: 20950149

Southern Brazil HIV Type 1 C Expansion into the State of São Paulo, Brazil

Overview
Publisher Mary Ann Liebert
Date 2010 Oct 19
PMID 20950149
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Abstract HIV diversity reflects multifactorial evolutionary forces, but monitoring subtype prevalence may provide clues to understanding the epidemic. In the Americas HIV-1 C is present at significant levels only in the southern states of Brazil. We describe in this study the presence of the HIV-1 C pol genome in 11.6% (95 CI 6-21%) of antiretroviral-naive individuals from São Paulo, the major city of South America, and 6.8% (95 CI 4-12%) from the second metropolitan area of the State of São Paulo, Brazil. Moreover, a significant growth trend of this subtype was documented among cases failing therapy in the area. Sequences were obtained by direct nested PCR from cDNA retrotranscribed from plasma RNA. Phylogenetic and amino acid signatures support an expansion from variants previously identified in southern Brazil. The evaluation of additional genomic regions (partial gag, envelope, and/or integrase) in samples with HIV-1 C at pol showed extensive recombination with clade B, observed in 47% of ARV-naive cases. The spread of HIV-1 C locally and to other areas of South America should be monitored as it may influence the dynamics of the epidemic.

Citing Articles

Dynamics and features of transmission clusters of HIV-1 subtypes in the state of São Paulo, Brazil.

Pimentel V, Pineda-Pena A, Sebastiao C, de Paula J, Ahagon C, Pingarilho M Front Public Health. 2024; 12:1384512.

PMID: 38903572 PMC: 11187794. DOI: 10.3389/fpubh.2024.1384512.


Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.

Soldi G, Ribeiro I, Ahagon C, Coelho L, Cabral G, Lopes G PLoS One. 2019; 14(10):e0223210.

PMID: 31574109 PMC: 6772045. DOI: 10.1371/journal.pone.0223210.


HIV-1 Molecular Epidemiology, Transmission Clusters and Transmitted Drug Resistance Mutations in Central Brazil.

Ortiz Tanaka T, Leite T, Freitas S, Cesar G, de Rezende G, de Siqueira Campos Lindenberg A Front Microbiol. 2019; 10:20.

PMID: 30804893 PMC: 6371026. DOI: 10.3389/fmicb.2019.00020.


Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.

Lima K, de Souza Leal E, Cavalcanti A, Salustiano D, de Medeiros L, da Silva S PLoS One. 2016; 11(5):e0155854.

PMID: 27218259 PMC: 4878750. DOI: 10.1371/journal.pone.0155854.


Assessing the HIV-1 Epidemic in Brazilian Drug Users: A Molecular Epidemiology Approach.

Guimaraes M, Marques B, Bertoni N, Teixeira S, Morgado M, Bastos F PLoS One. 2015; 10(11):e0141372.

PMID: 26536040 PMC: 4633026. DOI: 10.1371/journal.pone.0141372.